Withings
Company Overview
Mermaid diagram (expand to render)
Withings is a French consumer electronics company headquartered in Issy-les-Moulineaux, France, that designs and manufactures connected health devices and smart home health solutions. Founded in 2008 by CEO Eric Carreel, Withings has established itself as a leader in the connected health device market, with a focus on medical-grade consumer devices that bridge the gap between clinical accuracy and user-friendly design["@withings"]. The company operates as a subsidiary of Nokia Corporation following Nokia's acquisition of Withings in 2016, though it maintains its brand identity and operational independence.
| Attribute | Details |
|-----------|---------|
| Founded | 2008 |
| Headquarters | Issy-les-Moulineaux, France |
| Parent Company | Nokia (acquired 2016) |
| CEO | Eric Carreel |
| Employees | ~250 |
| Stock | Private |
| Website | [withings.com](https://www.withings.com) |
Corporate History and Development
Founding and Early Growth
Withings was founded by Eric Carreel, a serial entrepreneur with a vision for connected health devices that could help individuals monitor their health parameters in everyday settings. The company's early products included the Withings Smart Body Analyzer and connected scales, which established the brand's reputation for combining elegant industrial design with accurate health measurements. The company's name is a portmanteau of "with" and "things," reflecting its mission to connect everyday objects to the internet for health monitoring purposes.
Nokia Acquisition
In 2016, Nokia Corporation acquired Withings for approximately $192 million, recognizing the strategic importance of connected health devices in the emerging digital health market. Following the acquisition, Withings became part of Nokia's broader digital health strategy, though it retained its brand identity and continued developing consumer health devices under the Withings name. This acquisition positioned Withings within Nokia's ecosystem of connected devices while maintaining access to Nokia's distribution networks and technical resources.
Product Portfolio
Withings manufactures a comprehensive portfolio of connected health devices spanning multiple health monitoring categories[@withingsa].
Body Composition Monitoring
Withings Body Scan
The Withings Body Scan represents the company's most advanced body composition analyzer, incorporating multiple sensors for comprehensive metabolic monitoring[@withingsc]. Key features include:
- Bioelectrical Impedance Analysis (BIA): Measures body composition including body fat percentage, muscle mass, and water content
- Segmental Analysis: Provides body composition data for specific body regions (arms, legs, torso)
- Heart Rate Monitoring: Integrated sensors detect heart rate during measurement
- ECG Capability: FDA-cleared electrocardiogram functionality for atrial fibrillation detection
- Arterial Stiffness: Measures pulse wave velocity as an indicator of cardiovascular health
The Body Scan demonstrates Withings' evolution from simple consumer scales to sophisticated medical-grade monitoring devices, with potential applications in neurological conditions where body composition changes may reflect disease progression or medication effects.
Withings Body Med业内 Scale
The Withings Body Med业内 Scale represents the company's clinical-grade weighing solution designed for healthcare professional environments[@withingse]. This device maintains the consumer-friendly interface of Withings' consumer products while meeting medical device accuracy standards required for clinical use, supporting weight monitoring in patients with neurodegenerative diseases where weight loss and malnutrition are common complications.
Sleep Monitoring Technology
Withings Sleep Analyzer
The Withings Sleep Analyzer is a mattress-embedded sensor that provides comprehensive sleep tracking without requiring the user to wear any devices[@withingsd]. Key capabilities include:
- Sleep Cycle Analysis: Detects light, deep, and REM sleep stages using ballistocardiography
- Respiratory Monitoring: Detects sleep-disordered breathing events including apnea episodes
- Heart Rate Variability: Measures HRV as an indicator of autonomic nervous system function
- Snoring Detection: Identifies and quantifies snoring events
- Sleep Duration Tracking: Monitors total sleep time, time to sleep, and wake episodes
The Sleep Analyzer has significant applications in neurodegenerative disease monitoring, as sleep disorders are among the earliest and most prevalent non-motor symptoms in both Alzheimer's disease and Parkinson's disease[@delaune2020][@postuma2016].
Cardiovascular Monitoring
Withings ScanWatch
The Withings ScanWatch combines traditional watch design with medical-grade health monitoring capabilities:
- ECG Recording: FDA-cleared electrocardiogram for atrial fibrillation detection
- SpO2 Monitoring: Blood oxygen saturation measurement
- Heart Rate Tracking: Continuous heart rate monitoring with arrhythmia detection
- Activity Tracking: Step counting, workout detection, and movement analysis
- Sleep Tracking: Integrated sleep stage analysis
Connected Scales and Health Hubs
Withings Body
The Withings Body line of connected scales provides:
- Weight measurement with high-precision sensors
- Body composition analysis (body fat percentage, muscle mass)
- Automatic synchronization with the Withings Health Mate app
- Multi-user detection and tracking
- Pregnancy mode and baby weighing functionality
Withings Thermo
The Withings Thermo is a smart temporal artery thermometer that provides:
- Quick temperature measurement with 16 infrared sensors
- Automatic temperature tracking with date-stamped readings
- Fever alert notifications
- Integration with health tracking platforms
Application in Neurodegenerative Diseases
Parkinson's Disease
Withings devices offer several potential applications in Parkinson's disease monitoring and management[@berke2021][@sigcha2020]:
Movement Analysis
Wearable devices like ScanWatch can continuously monitor movement patterns, potentially detecting:
- Tremor characteristics including frequency, amplitude, and timing
- Gait abnormalities including shuffling, freezing of gait, and falls
- Bradykinesia through reduced movement frequency and amplitude
- Movement variability that may correlate with medication status[@godinho2016][@arslan2020]
Fall DetectionWithings devices with accelerometer sensors can detect falls, which are a significant concern in Parkinson's disease:
- Automatic fall detection algorithms
- Alert notifications to designated contacts
- Fall frequency tracking for clinical assessment
- Correlation with disease progression and medication status[@eriksson2019]
Activity MonitoringContinuous activity tracking provides insights into:
- Daily movement patterns and activity levels
- Exercise adherence and rehabilitation compliance
- Sedentary behavior and physical deconditioning
- Seasonal variation in activity levels
Sleep Monitoring Applications
Sleep disorders are extremely common in Alzheimer's disease and often precede cognitive decline by years[@schendan2019]. Withings Sleep Analyzer can monitor:
- Sleep architecture disruption including reduced slow-wave sleep
- Sleep fragmentation and frequent nighttime awakenings
- Circadian rhythm disturbances
- REM sleep behavior disorder (RBD), which may be a prodromal marker
Activity and Circadian PatternsChanges in daily activity patterns often accompany cognitive decline:
- Reduced physical activity and increased sedentary time
- Circadian rhythm disturbances
- Wandering behavior patterns
- Reduced engagement in daily activities
Weight and Nutritional MonitoringMalnutrition and weight loss are common complications in dementia:
- Regular weight tracking to detect progressive weight loss
- Body composition changes indicating muscle wasting (sarcopenia)
- Monitoring nutritional status in home-based care settings
Sleep Disorders and Neurodegeneration
The connection between sleep disorders and neurodegenerative diseases represents one of the most important frontiers in research[@delaune2020][@postuma2016]. Withings' sleep monitoring technology provides:
Longitudinal Sleep Data
- Nightly sleep quality metrics over extended periods
- Detection of sleep pattern changes that may indicate disease progression
- Correlation between sleep quality and cognitive or motor symptoms
Specific Sleep Disorder Detection
- REM Sleep Behavior Disorder (RBD): Often a prodromal marker of synucleinopathies including Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies. Withings Sleep Analyzer can detect movements during sleep that may indicate RBD.
- Obstructive Sleep Apnea (OSA): Highly prevalent in neurodegenerative diseases and may accelerate disease progression through intermittent hypoxia and cardiovascular stress.
- Insomnia: Primary insomnia and insomnia secondary to neurodegenerative disease can be monitored longitudinally.
Research ApplicationsWithings devices have been used in research studies investigating:
- Sleep-dependent clearance of neurotoxic proteins including amyloid-beta and alpha-synuclein
- Circadian rhythm alterations in neurodegenerative diseases
- Correlation between sleep metrics and disease biomarkers
- Effects of therapeutic interventions on sleep parameters
Clinical Research Applications
Withings devices have been deployed in clinical research settings for neurodegenerative disease studies:
Clinical Trial Endpoints
- Digital biomarkers for clinical trial outcome measures
- Continuous monitoring between clinic visits
- Real-world evidence generation
- Patient-reported outcome measures through app-based questionnaires
Remote Patient Monitoring
- Home-based monitoring reducing clinic visit frequency
- Continuous data collection for disease progression assessment
- Medication response monitoring through symptom tracking
- Caregiver burden reduction through automated monitoring
Cohort Studies
- Population-based studies investigating prodromal markers
- Longitudinal studies tracking disease progression
- Cross-sectional studies comparing patient populations
- Biomarker validation studies
Withings Health Mate Application
The Withings Health Mate application serves as the central platform for data aggregation and analysis:
- Data Synchronization: Automatic data synchronization from all Withings devices
- Trend Analysis: Historical data visualization and trend identification
- Integration Capabilities: Connects with Apple Health, Google Fit, and other platforms
- Healthcare Provider Features: Professional dashboard for clinical users
- Research Data Export: Capabilities for research data sharing
Withings provides API access for healthcare provider integration:
- FHIR Integration: Healthcare data interoperability standards
- EHR Integration: Electronic health record system connections
- Clinical Decision Support: Integration with clinical workflows
- Research Platforms: Data export for research purposes
Data Security and Privacy
Withings maintains data security through:
- End-to-end encryption for data transmission
- Secure cloud storage with industry-standard protocols
- GDPR compliance for European users
- HIPAA-compliant options for healthcare applications
Competitive Landscape
Withings operates in the connected health device market with several competitive dynamics[@withingsa]:
| Competitor | Primary Focus | Key Products |
|------------|---------------|---------------|
| Apple | Consumer wearables, health integration | Apple Watch, iPhone Health |
| Samsung | Smartwatches, health ecosystem | Galaxy Watch, Samsung Health |
| Oura | Sleep and recovery tracking | Oura Ring |
| Whoop | Fitness and recovery monitoring | Whoop 4.0 |
| Fitbit (Google) | Consumer fitness, health tracking | Fitbit Sense, Charge |
| Garmin | Fitness and outdoor wearables | Fenix, Vivo series |
Competitive Differentiation
Withings differentiates through several strategic factors:
Medical Device Heritage: While competitors focus primarily on consumer wellness, Withings has pursued medical device clearances (FDA, CE) for key products, positioning them for clinical use.
European Market Presence: Strong brand recognition and market share in European markets, particularly France and Northern Europe, provides a geographic advantage.
Design Excellence: Recognition for industrial design through awards and aesthetic appeal, making health monitoring devices more approachable.
Sleep Technology Focus: Significant investment in sleep monitoring technology, including mattress-embedded sensors, provides differentiation in a key health monitoring area.
Multi-Device Ecosystem: Comprehensive product portfolio enables multi-parameter monitoring through a single brand ecosystem.Clinical Validation and Research
Regulatory Clearances
Withings has obtained regulatory clearances for several medical device features:
- FDA Clearance: ScanWatch ECG functionality, Body Scan features
- CE Marking: European medical device certification for clinical-grade features
- Medical Device ISO Certification: ISO 13485 quality management systems for medical devices
Published Research
Withings devices have been used in various published research studies:
- Validation studies for weight and body composition measurement accuracy
- Sleep monitoring validation against polysomnography
- Cardiovascular parameter accuracy studies
- Consumer health device utility in chronic disease management
Future Directions and Strategic Outlook
Product Development Roadmap
Withings has indicated several areas of potential expansion relevant to neurodegenerative diseases:
Enhanced Neurological Monitoring: Development of algorithms specific to movement disorders including Parkinson's disease tremor analysis and gait pattern recognition
Clinical Trial Integration: Providing validated endpoint measures for neurodegenerative disease therapeutic trials
Healthcare Provider Partnerships: Direct integration with neurology practice workflows and electronic health records
AI/ML Development: Machine learning models for disease progression tracking based on longitudinal multi-parameter data
Biomarker Discovery: Investigating digital biomarkers from continuous monitoring data that may correlate with disease progressionMarket Opportunity
The intersection of connected health devices and neurodegenerative disease represents a significant market opportunity:
- Aging Population: Global demographic shifts increase prevalence of Alzheimer's disease and Parkinson's disease
- Remote Monitoring Demand: COVID-19 accelerated adoption of remote patient monitoring
- Digital Therapeutics Growth: Integration of monitoring devices with digital therapeutic platforms
- Value-Based Care: Healthcare system transition to value-based care models emphasizing outcomes over volume
Strategic Partnerships
Potential strategic directions include:
- Healthcare System Partnerships: Integration with healthcare delivery organizations for chronic disease management
- Pharmaceutical Collaboration: Partnership with pharmaceutical companies for clinical trial endpoints and patient monitoring
- Research Institution Collaboration: Academic partnerships for digital biomarker validation
- Payer Integration: Collaboration with health insurance companies for covered device programs
Regulatory and Reimbursement Considerations
Regulatory Landscape
Connected health devices for neurodegenerative disease monitoring face evolving regulatory requirements:
- FDA Digital Health Initiatives: Ongoing FDA guidance development for digital health devices
- Software as Medical Device (SaMD): Regulatory frameworks for software-based medical devices
- Cybersecurity Requirements: Increasing cybersecurity requirements for connected medical devices
Reimbursement Pathways
Current reimbursement landscape for connected health devices:
- Traditional Medicare: Limited coverage for consumer health devices
- Medicare Advantage: Some coverage through Medicare Advantage plans
- Private Insurance: Variable coverage depending on specific device and indication
- Direct-to-Consumer: Primary business model with consumer out-of-pocket payment
Implementation Considerations
For Healthcare Providers
Healthcare systems considering Withings integration should evaluate:
Device Selection: Matching device capabilities to specific monitoring needs
Integration Requirements: Technical requirements for EHR and clinical system integration
Workflow Integration: How monitoring data will be incorporated into clinical workflows
Staff Training: Education requirements for clinical staff interpreting device data
Patient Support: Resources for patient education and device setupFor Patients and Caregivers
Patients and caregivers implementing Withings devices should consider:
Device Selection: Choosing appropriate devices based on specific monitoring needs
Setup and Configuration: Initial device setup and account creation
Data Interpretation: Understanding how to interpret monitoring data
Clinical Communication: How to effectively communicate data to healthcare providers
Long-term Adherence: Strategies for maintaining consistent device use over timeCross-Links
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Sleep Disorders in Neurodegeneration](/mechanisms/sleep-neurodegeneration-connection)
- [Digital Biomarkers](/mechanisms/digital-biomarkers-parkinsons-disease)
- [Wearable Technologies for Parkinson's Disease](/companies/wearable-technologies-parkinsons-disease)
- [Remote Patient Monitoring](/mechanisms/remote-patient-monitoring-neurodegeneration)
References
[Withings Official Website](https://www.withings.com)
[Withings Health Solutions](https://www.withings.com/health-solutions)
[Withings Sleep Technology](https://www.withings.com/sleep)
[Withings Body Scan](https://www.withings.com/body-scan)
[Withings Sleep Analyzer](https://www.withings.com/sleep-analyzer)
[Withings Med业内 Scale](https://www.withings.com/med-scale)
[Berkemkamp SM, et al, Wearable sensors for movement analysis in Parkinson's disease, Sensors (2021)](https://pubmed.ncbi.nlm.nih.gov/33920939/)
[Sigcha L, et al, Automatic resting tremor detection in Parkinson's disease using smartwatches, Sensors (2020)](https://pubmed.ncbi.nlm.nih.gov/33211856/)
[Delaune V, et al, Sleep disorders and neurodegenerative diseases, Sleep Med Clin (2020)](https://pubmed.ncbi.nlm.nih.gov/32912661/)
[Postuma RB, et al, Sleep disorders and neurodegenerative disease, Nat Rev Neurol (2016)](https://pubmed.ncbi.nlm.nih.gov/27032479/)
[Schendan HE, et al, Sleep is associated with beta-amyloid clearance, J Alzheimers Dis (2019)](https://pubmed.ncbi.nlm.nih.gov/31204227/)
[Ibanez V, et al, Gait disorders and falls in Parkinson disease, Nat Rev Neurol (2020)](https://pubmed.ncbi.nlm.nih.gov/32341499/)
[Warmerdam E, et al, Long-term home monitoring of Parkinson's disease, J Parkinsons Dis (2021)](https://pubmed.ncbi.nlm.nih.gov/34212254/)
[Singleton C, et al, Tremor quantification using wearable sensors in Parkinson's disease, J Parkinsons Dis (2019)](https://pubmed.ncbi.nlm.nih.gov/31156120/)
[Godinho C, et al, Systematic review of wearable motion sensors for Parkinson's disease, Gait Posture (2016)](https://pubmed.ncbi.nlm.nih.gov/27613480/)
[Arslan A, et al, Wearable sensors for objective monitoring of Parkinson's disease, Sensors (2020)](https://pubmed.ncbi.nlm.nih.gov/33260723/)
[Meyer J, et al, Digital biomarkers in movement disorders, Nat Rev Neurol (2021)](https://pubmed.ncbi.nlm.nih.gov/34050303/)
[Johansson D, et al, Wearable sensor-based gait analysis for Parkinson's disease, Sensors (2019)](https://pubmed.ncbi.nlm.nih.gov/30691025/)
[Heldman DA, et al, Continuous monitoring of Parkinson's disease symptoms, J Parkinsons Dis (2017)](https://pubmed.ncbi.nlm.nih.gov/28436383/)
[Vasquez L, et al, Machine learning for Parkinson's disease diagnosis and monitoring, Nat Rev Neurol (2021)](https://pubmed.ncbi.nlm.nih.gov/34108676/)
[Adams JL, et al, Real-world digital biomarkers for Parkinson's disease, Nat Rev Neurol (2021)](https://pubmed.ncbi.nlm.nih.gov/34050303/)